Emerging therapies targeting lipoprotein(a): the next frontier in cardiovascular risk reduction
Lipoprotein(a) [Lp(a)] is a genetically determined lipoprotein particle composed of apolipoprotein B-100 covalently linked to apolipoprotein(a) [apo(a)] via a disulfide bond. The Lp(a) particle is enriched with oxidized phospholipids (OxPLs), which confer enhanced atherogenic and pro-inflammatory pr...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2025-12-01
|
| Serier: | Frontiers in Medicine |
| Fag: | |
| Online adgang: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1727918/full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|